Why Silicon Valley is bringing eugenics back
By Paris Marx,
Disconnect
| 04. 21. 2023
Elon Musk has been warning about population decline and smaller families for years. In his 2015 biography, he’s quoted as saying, “if each successive generation of smart people has fewer kids, that’s probably bad.” Musk is explicit that “smart” people need to be having more kids — he has nine living children, that we know of — but doesn’t go so far as to say that other people should be having fewer. After all, he does want the population to grow.
One of the problems with his narrative is that the global population is growing — it hit 8 billion people last year — as is the US population, though the rates of growth are slowing. Musk, however, acts as though we’re already in a state of decline, which suggests he’s more concerned with the growth rate of particular segments of the population than the population as a whole — as his concern about the procreation of “smart” people suggests.
Almost as long as Musk has been talking about this, there have been questions about how those concerns were reflected...
Related Articles
By Liyan Qi and Jonathan Cheng, The Wall Street Journal | 03.26.2025
photo via Wikimedia Commons licensed under CC by 3.0
Chinese scientist He Jiankui set off global outrage and landed in prison after he skirted ethical guidelines and claimed he had produced genetically modified babies designed to resist HIV infection.
Now, the self-styled ...
By Carsten T. Charlesworth, Henry T. Greely, and Hiromitsu Nakauchi, MIT Technology Review | 03.25.2025
Why do we hear about medical breakthroughs in mice, but rarely see them translate into cures for human disease? Why do so few drugs that enter clinical trials receive regulatory approval? And why is the waiting list for organ transplantation...
By Anna Louie Sussman, The New York Times | 03.25.2025
On June 24, 2022, the same day the Supreme Court issued its decision in Dobbs v. Jackson Women’s Health Organization, I received a call from the fertility clinic where I’d been undergoing in vitro fertilization, informing me that seven of...
By Michael Gibney, PharmaVoice | 03.20.2025
The death this week of a teenager receiving Sarepta Therapeutics’ gene therapy Elevidys for Duchenne muscular dystrophy is a tragic reminder of the stakes involved in cutting-edge biotech innovation.
While gene therapies like Sarepta’s offer an opportunity to treat and...